Announced Tue, 31 Mar · 22:59 IST

The Company has entered into Strategic Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon, USA

Marquee Jv AnnouncedStrategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+24.9%1-day move
₹216.00
prior close
₹233.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+0.6+0.6+2.3+24.9+31.9+28.2+28.7+29.6+36.5+35.6+36.6+84.0+75.7
Up moveDown movePending
AI summary

Hemant Surgical Industries Ltd has signed a strategic Semi Knocked Down (SKD) manufacturing agreement with Sonomed Escalon, USA, a global leader in ophthalmic diagnostic imaging. Under the deal, Hemant Surgical will initially assemble SKD kits and eventually move to 100% local manufacturing in India for ophthalmic ultrasound diagnostic devices. Sonomed Escalon will supply components to Hemant Surgical at a preferential 'Transfer Price,' with taxes, duties, and shipping handled separately. The company has clarified this is not a related party transaction, although the promoter was previously an authorised distributor of Sonomed Escalon. No specific financial value or volume commitment for the deal has been disclosed.

Likely market impact

This agreement strengthens Hemant Surgical's position in the ophthalmic devices segment and adds a globally respected partner to its portfolio, which could support future revenue growth and margin improvement through local manufacturing. For shareholders, it is a positive strategic move, though the absence of deal size details limits visibility on near-term financial impact.